Pharmaceuticals, Biotechnology and Life Sciences
SYDNEY–(BUSINESS WIRE)–Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced that Veyonda has been approved to move into the second and final stage of the NOXCOVID-1 clinical trial on the advice of the study’s clini…
SYDNEY–(BUSINESS WIRE)–Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced that Veyonda has been approved to move into the second and final stage of the NOXCOVID-1 clinical trial on the advice of the study’s clini…
Veteran Industry Executive joins Delix from Atlas Venture, after previously leading Shire Pharmaceuticals’ Global Neuroscience Business
Delix has identified a class of non-hallucinogenic versions of psychedelic compounds, which the company is deve…
DUBLIN–(BUSINESS WIRE)–The “Cancer Monoclonal Antibodies Market 2020-2026” report has been added to ResearchAndMarkets.com’s offering.
The global cancer monoclonal antibodies market is estimated to witness significant growth during the forecast peri…
DUBLIN–(BUSINESS WIRE)–The “Cancer Monoclonal Antibodies Market 2020-2026” report has been added to ResearchAndMarkets.com’s offering.
The global cancer monoclonal antibodies market is estimated to witness significant growth during the forecast peri…
DUBLIN–(BUSINESS WIRE)–The “Cancer Monoclonal Antibodies Market 2020-2026” report has been added to ResearchAndMarkets.com’s offering.
The global cancer monoclonal antibodies market is estimated to witness significant growth during the forecast peri…
Ms. Haukioja will leverage more than 25 years of progressive pharmaceutical experience to provide strategic guidance to ZYUS’ clinical trial programs
SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”), a Canadian life sciences …
Issued Patents in major markets including the U.S., Australia, China, and Japan
PETACH TIKVA, Israel–(BUSINESS WIRE)–$CANF–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary sma…
ATLANTA–(BUSINESS WIRE)–Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, today reported…
ATLANTA–(BUSINESS WIRE)–Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat diseases associated with virally triggered or maintained immune responses, today reported…